Integrated Filing — IndAS
General information about company
| Scrip Code |
524742 |
| NSE Symbol |
CAPLIPOINT |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE475E01026 |
| Name of company |
CAPLIN POINT LABORATORIES LIMITED |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
05-11-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
29-10-2025 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Second quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Geographical |
| Description of single segment |
|
| Start date and time of board meeting |
05-11-2025 10:55:00 |
| End date and time of board meeting |
05-11-2025 13:15:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Not applicable |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
53,404.00 |
1,04,426.00 |
|
Other income |
3,037.00 |
5,351.00 |
|
Total income |
56,441.00 |
1,09,777.00 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
9,234.00 |
16,585.00 |
| (b) |
Purchases of stock-in-trade |
12,168.00 |
23,518.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(372.00) |
451.00 |
| (d) |
Employee benefit expense |
4,723.00 |
9,039.00 |
| (e) |
Finance costs |
16.00 |
34.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
1,840.00 |
3,469.00 |
| (f) |
Other Expenses |
| 1 |
Other Expenses |
8,734.00 |
18,140.00 |
|
Total other expenses |
8,734.00 |
18,140.00 |
|
Total expenses |
36,343.00 |
71,236.00 |
| 3 |
Total profit before exceptional items and tax |
20,098.00 |
38,541.00 |
| 4 |
Exceptional items |
0.00 |
0.00 |
| 5 |
Total profit before tax |
20,098.00 |
38,541.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
3,653.00 |
6,963.00 |
| 8 |
Deferred tax |
424.00 |
484.00 |
| 9 |
Total tax expenses |
4,077.00 |
7,447.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
16,021.00 |
31,094.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
2.00 |
5.00 |
| 16 |
Total profit (loss) for period |
16,023.00 |
31,099.00 |
| 17 |
Other comprehensive income net of taxes |
4,754.00 |
4,790.00 |
| 18 |
Total Comprehensive Income for the period |
20,777.00 |
35,889.00 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
15,445.00 |
30,725.00 |
|
Total profit or loss, attributable to non-controlling interests |
578.00 |
374.00 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
20,199.00 |
35,515.00 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
578.00 |
374.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
1,520.00 |
1,520.00 |
|
Face value of equity share capital |
2 |
2 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
20.32 |
40.42 |
|
Diluted earnings (loss) per share from continuing operations |
20.25 |
40.28 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
20.32 |
40.42 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
20.25 |
40.28 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2025 |
| Date of end of reporting period |
30-09-2025 |
| Whether results are audited or unaudited |
Unaudited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
52,348.00 |
|
Capital work-in-progress |
17,695.00 |
|
Investment property |
|
|
Goodwill |
0.00 |
|
Other intangible assets |
2,612.00 |
|
Intangible assets under development |
561.00 |
|
Biological assets other than bearer plants |
|
|
Investments accounted for using equity method |
|
|
Non-current financial assets |
|
|
Non-current investments |
26,636.00 |
|
Trade receivables, non-current |
0.00 |
|
Loans, non-current |
0.00 |
|
Other non-current financial assets |
9,248.00 |
|
Total non-current financial assets |
35,884.00 |
|
Deferred tax assets (net) |
0.00 |
|
Other non-current assets |
8,480.00 |
|
Total non-current assets |
1,17,580.00 |
| 2 |
Current assets |
|
|
Inventories |
32,943.00 |
|
Current financial asset |
|
|
Current investments |
37,011.00 |
|
Trade receivables, current |
69,445.00 |
|
Cash and cash equivalents |
10,826.00 |
|
Bank balance other than cash and cash equivalents |
53,883.00 |
|
Loans, current |
0.00 |
|
Other current financial assets |
5,932.00 |
|
Total current financial assets |
1,77,097.00 |
|
Current tax assets (net) |
0.00 |
|
Other current assets |
22,772.00 |
|
Total current assets |
2,32,812.00 |
| 3 |
Non-current assets classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
0.00 |
|
Total assets |
3,50,392.00 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
1,520.00 |
|
Other equity |
3,14,415.00 |
|
Total equity attributable to owners of parent |
3,15,935.00 |
|
Non controlling interest |
3,964.00 |
|
Total equity |
3,19,899.00 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
0.00 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
0.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
0.00 |
|
Total Trade payable |
0.00 |
|
Other non-current financial liabilities |
1,306.00 |
|
Total non-current financial liabilities |
1,306.00 |
|
Provisions, non-current |
105.00 |
|
Deferred tax liabilities (net) |
273.00 |
|
Deferred government grants, Non-current |
0.00 |
|
Other non-current liabilities |
319.00 |
|
Total non-current liabilities |
2,003.00 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
49.00 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
225.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
20,690.00 |
|
Total Trade payable |
20,915.00 |
|
Other current financial liabilities |
4,602.00 |
|
Total current financial liabilities |
25,566.00 |
|
Other current liabilities |
1,150.00 |
|
Provisions, current |
1,774.00 |
|
Current tax liabilities (Net) |
|
|
Deferred government grants, Current |
|
|
Total current liabilities |
28,490.00 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
|
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
|
|
Total liabilities |
30,493.00 |
|
Total equity and liabilites |
3,50,392.00 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| Date of end of reporting
period |
30-09-2025 |
30-09-2025 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
Rest of the World |
42,708.00 |
83,061.00 |
| 2 |
USA |
10,696.00 |
21,365.00 |
| 3 |
Unallocated |
3,037.00 |
5,351.00 |
|
Total Segment Revenue |
56,441.00 |
1,09,777.00 |
|
Less: Inter segment revenue |
0.00 |
0.00 |
|
Revenue from operations |
56,441.00 |
1,09,777.00 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
Rest of the World |
15,610.00 |
30,756.00 |
| 2 |
USA |
1,453.00 |
2,439.00 |
| 3 |
Unallocated |
3,037.00 |
5,351.00 |
|
Total Profit before tax |
20,100.00 |
38,546.00 |
|
i. Finance cost |
0.00 |
0.00 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
0.00 |
0.00 |
|
Profit before tax |
20,100.00 |
38,546.00 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
Rest of the World |
1,58,842.00 |
1,58,842.00 |
| 2 |
USA |
58,133.00 |
58,133.00 |
| 3 |
Unallocated |
0.00 |
0.00 |
|
Total Segment Asset |
2,16,975.00 |
2,16,975.00 |
|
Un-allocable Assets |
1,33,417.00 |
1,33,417.00 |
|
Net Segment Asset |
3,50,392.00 |
3,50,392.00 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
Rest of the World |
25,139.00 |
25,139.00 |
| 2 |
USA |
5,354.00 |
5,354.00 |
| 3 |
Unallocated |
0.00 |
0.00 |
|
Total Segment Liabilities |
30,493.00 |
30,493.00 |
|
Un-allocable Liabilities |
0.00 |
0.00 |
|
Net Segment Liabilities |
30,493.00 |
30,493.00 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Remeasurements of Defined Benefit Plan |
134.00 |
134.00 |
|
Total Amount of items that will not be reclassified to profit and loss |
134.00 |
134.00 |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
34.00 |
34.00 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
FCTR |
4,654.00 |
4,690.00 |
|
Total Amount of items that will be reclassified to profit and loss |
4,654.00 |
4,690.00 |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
0.00 |
0.00 |
| 5 |
Total Other comprehensive income |
4,754.00 |
4,790.00 |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
38,541.00 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
34.00 |
|
Adjustments for decrease (increase) in inventories |
994.00 |
|
Adjustments for decrease (increase) in trade receivables, current |
(5,554.00) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
(2,065.00) |
|
Adjustments for decrease (increase) in other non-current assets |
0.00 |
|
Adjustments for other financial assets, non-current |
(750.00) |
|
Adjustments for other financial assets, current |
0.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
(2,809.00) |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
0.00 |
|
Adjustments for increase (decrease) in other non-current liabilities
|
0.00 |
|
Adjustments for depreciation and amortisation expense |
3,469.00 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
0.00 |
|
Adjustments for provisions, current |
0.00 |
|
Adjustments for provisions, non-current |
0.00 |
|
Adjustments for other financial liabilities, current |
0.00 |
|
Adjustments for other financial liabilities, non-current |
0.00 |
|
Adjustments for unrealised foreign exchange losses gains |
(615.00) |
|
Adjustments for dividend income |
0.00 |
|
Adjustments for interest income |
3,673.00 |
|
Adjustments for share-based payments |
(68.00) |
|
Adjustments for fair value losses (gains) |
(268.00) |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
0.00 |
|
Other adjustments to reconcile profit (loss) |
(269.00) |
|
Other adjustments for non-cash items |
4,869.00 |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
5.00 |
|
Total adjustments for reconcile
profit (loss) |
(6,700.00) |
|
Net cash flows from (used in)
operations |
31,841.00 |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
6,467.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
25,374.00 |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
0.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
5.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
0.00 |
|
Purchase of property, plant and equipment |
9,388.00 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
0.00 |
|
Interest received |
3,313.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
(23,829.00) |
|
Net cash flows from (used in)
investing activities |
(29,909.00) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
0.00 |
|
Proceeds from issuing other equity instruments |
0.00 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
0.00 |
|
Repayments of borrowings |
6.00 |
|
Payments of lease liabilities |
0.00 |
|
Dividends paid |
4,561.00 |
|
Interest paid |
34.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
financing activities |
(4,601.00) |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
(9,136.00) |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
17.00 |
|
Net increase (decrease) in cash
and cash equivalents |
(9,119.00) |
|
Cash and cash equivalents cash flow statement at beginning of period
|
19,945.00 |
|
Cash and cash equivalents cash
flow statement at end of period |
10,826.00 |